Literature DB >> 6614317

Surgical management of gallstones in cirrhotic patients.

D Castaing, D Houssin, J Lemoine, H Bismuth.   

Abstract

Among the cirrhotic patients admitted to our department, 64 (17 percent) were found to have cholelithiasis. In 14 patients (22 percent), cholelithiasis caused cholecystitis, obstructive jaundice, or biliary pain. These 14 patients were operated on and underwent cholecystectomy. There was one postoperative complication (gastrointestinal bleeding from esophageal varices) and one death (due to acute respiratory failure). In 50 patients (78 percent) cholelithiasis was asymptomatic. Ten of the 50 patients died from liver failure and the stones were discovered at necropsy. Seven of the patients had radiographically demonstrated stones that were not operated on. They are alive at the present time, more than 2 years later. In the remaining 33 patients, the stones were discovered during portasystemic shunt procedures. In these patients, cholelithiasis was systematically treated by cholecystectomy (8 patients) or cholecystolithotomy (25 patients). Postoperative mortality and morbidity rates were not different in these 33 patients when compared with the rates in 170 patients who underwent portal surgery alone during the same period. Our results confirm the high incidence of cholelithiasis in cirrhotic patients. Complications of gallstones are not frequent but require an emergency operation that carries a high risk in these patients. On the other hand, elective surgical treatment of asymptomatic cholelithiasis at the time of portal diversion does not bear any peculiar risk. In such a situation, cholecystolithotomy is easier and probably safer than cholecystectomy.

Entities:  

Mesh:

Year:  1983        PMID: 6614317     DOI: 10.1016/0002-9610(83)90403-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  15 in total

1.  Deaths from gallstones. Incidence and associated clinical factors.

Authors:  G Cucchiaro; C R Watters; J C Rossitch; W C Meyers
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

2.  Outcome of biliary tract surgery in unknown cirrhotics: a case-control study.

Authors:  S Hamid; M Siddiqui; W Jafri; H Shah; H Khan; M Ahmed
Journal:  Ann R Coll Surg Engl       Date:  1993-11       Impact factor: 1.891

Review 3.  Gallstones in chronic liver disease.

Authors:  Michael Anthony Silva; Terence Wong
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

4.  Cirrhosis and alcoholism as pathogenetic factors in pigment gallstone formation.

Authors:  W H Schwesinger; W E Kurtin; B A Levine; C P Page
Journal:  Ann Surg       Date:  1985-03       Impact factor: 12.969

5.  Treatment of choledocholithiasis in patients with liver cirrhosis. Surgical treatment or endoscopic sphincterotomy?

Authors:  M Sugiyama; Y Atomi; A Kuroda; T Muto
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

Review 6.  Gallstones in patients with liver cirrhosis: incidence, etiology, clinical and therapeutical aspects.

Authors:  Monica Acalovschi
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

7.  Management of gallstones in cirrhotic patients.

Authors:  Y Ishizaki; Y Bandai; K Shimomura; K Shimada; M Hashimoto; K Sanjyo; Y Idezuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Surgery for cholelithiasis in cirrhotic patients.

Authors:  H Isozaki; K Okajima; S Morita; T Ishibashi; M Tanimura; H Hara; Y Takeda
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  Incidence of cholelithiasis among patients with cirrhosis and portal hypertension.

Authors:  H V Steinberg; W W Beckett; J L Chezmar; W E Torres; F B Murphy; M E Bernardino
Journal:  Gastrointest Radiol       Date:  1988-10

10.  Natural history of cholelithiasis in patients with alcoholic cirrhosis (cholelithiasis in cirrhotic patients).

Authors:  G Dunnington; E Alfrey; R Sampliner; F Kogan; C Putnam
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.